CLRB
Cellectar Biosciences, Inc.
Company overview
- Market capitalization
- $17.30M
- Employees
- 11
- Latest publication
- 2026-09-29
About Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States. The company's lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. It also develops CLR125, an iodine-125 Auger-emitting radioconjugate program; and CLR 225, an actinium-225 based program. The company has collaborative with Orano Med to develop alpha emitter lead-212 conjugated to phospholipid ether series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 309,022USD | 0USD | 0USD |
| Cost Of Revenue | -110,018USD | 49,461USD | 52,277USD | — | 56,295USD | — | 68,571USD | — |
| Gross Profit | 110,018USD | -49,461USD | -52,277USD | — | -56,295USD | 154,511USD | -68,571USD | — |
| Research Development | 3,007,229USD | 3,158,561USD | 2,523,305USD | 2,389,801USD | 3,427,095USD | 6,209,227USD | 5,493,496USD | 7,345,480USD |
| Selling General Administrative | 2,786,713USD | 2,532,068USD | 2,327,391USD | 3,647,728USD | 2,973,896USD | 6,535,599USD | 7,834,181USD | 6,358,229USD |
| Total Operating Expenses | 5,903,960USD | 5,690,629USD | 4,850,696USD | 6,037,529USD | 6,400,991USD | 12,744,826USD | 13,327,677USD | 13,703,709USD |
| Operating Income | -5,793,942USD | -5,690,629USD | -4,850,696USD | -6,037,529USD | -6,400,991USD | -12,744,826USD | -13,327,677USD | -13,703,709USD |
| Interest Income | 62,996USD | 97,575USD | 112,543USD | 88,020USD | 136,962USD | 244,210USD | 317,887USD | 328,907USD |
| Net Interest Income | 62,996USD | 97,575USD | 112,543USD | 88,020USD | 136,962USD | 244,210USD | 317,887USD | 328,907USD |
| Income Before Tax | -5,653,946USD | -5,295,221USD | -4,443,877USD | -5,447,911USD | -6,604,029USD | -2,289,373USD | -14,664,719USD | -919,371USD |
| Net Income | -5,653,946USD | -5,295,221USD | -4,443,877USD | -5,447,911USD | -6,604,029USD | -2,355,373USD | -14,664,719USD | -919,371USD |
| Net Income From Continuing Ops | -5,653,946USD | -5,295,221USD | -4,443,877USD | -5,447,911USD | -6,604,029USD | -2,355,373USD | -14,664,719USD | -919,371USD |
| Ebit | -5,793,942USD | -5,690,629USD | -4,850,696USD | -6,037,529USD | -6,400,991USD | -12,744,826USD | -13,327,677USD | -13,703,709USD |
| Ebitda | -5,903,960USD | -5,641,168USD | -4,798,419USD | -5,981,965USD | -6,344,696USD | -12,676,255USD | -13,259,106USD | — |
| Depreciation And Amortization | -110,018USD | 49,461USD | 52,277USD | 55,564USD | 56,295USD | 68,571USD | 68,571USD | — |
| Reconciled Depreciation | -110,018USD | 49,461USD | 52,277USD | 55,564USD | 56,295USD | 68,571USD | 68,571USD | 66,021USD |
| Total Other Income Expense Net | 139,996USD | 395,408USD | 406,819USD | 589,618USD | -203,038USD | 10,455,453USD | -1,337,042USD | 12,455,431USD |
| Income Tax Expense | — | — | — | — | — | 66,000USD | 45,214USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | 88,490USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 213,597USD | 291,653USD | 192,375USD | 238,867USD | 227,636USD | 207,929USD | 189,360USD | 82,265USD |
| Gross Profit | -213,597USD | -291,653USD | -192,375USD | -238,867USD | -227,636USD | -207,929USD | -189,360USD | -82,265USD |
| Research Development | 11,498,761USD | 26,136,245USD | 27,266,276USD | 19,219,603USD | 17,586,469USD | 10,140,681USD | 8,996,058USD | 6,835,229USD |
| Selling General Administrative | 11,481,083USD | 25,641,453USD | 11,694,367USD | 9,594,170USD | 6,544,811USD | 5,149,668USD | 5,182,566USD | 4,820,073USD |
| Total Operating Expenses | 22,766,247USD | 51,777,698USD | 38,960,643USD | 28,813,773USD | 24,131,280USD | 15,290,349USD | 13,989,264USD | 11,655,302USD |
| Operating Income | -22,979,844USD | -51,777,698USD | -38,960,643USD | -28,813,773USD | -24,131,280USD | -15,290,349USD | -14,178,624USD | -13,330,764USD |
| Interest Income | 435,100USD | 1,210,853USD | 395,369USD | 152,519USD | 2,284USD | 10,897USD | 85,710USD | 91,740USD |
| Net Interest Income | 435,100USD | 1,210,853USD | 395,369USD | 152,519USD | 2,284USD | 10,897USD | 42,712USD | 29,687USD |
| Income Before Tax | -21,791,037USD | -44,515,446USD | -42,830,610USD | -28,661,254USD | -24,122,362USD | -15,094,172USD | -14,092,912USD | -13,239,027USD |
| Tax Provision | 0USD | 66,000USD | -60,000USD | -60,000USD | 0USD | — | — | — |
| Net Income | -21,791,037USD | -44,581,446USD | -42,770,610USD | -28,601,254USD | -23,970,163USD | -15,094,172USD | -14,092,912USD | -13,239,027USD |
| Net Income From Continuing Ops | -21,791,037USD | -44,581,446USD | -37,749,931USD | -28,601,254USD | -24,122,362USD | -15,094,172USD | -14,092,912USD | -13,239,027USD |
| Ebit | -22,979,844USD | -51,777,698USD | -38,960,643USD | -28,813,773USD | -24,131,280USD | -15,094,172USD | -14,092,912USD | -13,239,027USD |
| Ebitda | -22,766,247USD | -51,486,045USD | -38,768,268USD | -28,665,338USD | -23,981,365USD | -14,886,243USD | -13,903,552USD | -13,156,762USD |
| Depreciation And Amortization | 213,597USD | 291,653USD | 192,375USD | 148,435USD | 149,915USD | 207,929USD | 189,360USD | 82,265USD |
| Reconciled Depreciation | 213,597USD | 291,653USD | 160,574USD | 148,435USD | 149,915USD | 141,453USD | 132,798USD | 82,265USD |
| Total Other Income Expense Net | 1,188,807USD | 7,262,252USD | -3,869,967USD | 152,519USD | 8,918USD | 196,177USD | 85,712USD | -1,583,725USD |
| Selling And Marketing Expenses | — | 945,184USD | 945,184USD | — | — | — | — | — |
| Income Tax Expense | — | 66,000USD | -60,000USD | -60,000USD | -152,199USD | -337,630USD | -218,510USD | -1,554,038USD |
| Interest Expense | — | — | — | 300,954USD | 2,284USD | 10,897USD | 42,712USD | 29,687USD |
| Net Income Applicable To Common Shares | — | — | — | -28,601,254USD | -24,122,362USD | -15,094,172USD | -14,092,912USD | -15,480,822USD |
| Non Operating Income Net Other | — | — | — | — | — | 185,280USD | 43,000USD | 62,050USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 36,639,086USD | 11,119,761USD | 14,978,321USD | 14,627,590USD | 13,695,183USD | 16,042,190USD | 25,474,047USD | 37,293,266USD |
| Cash And Equivalents | 33,993,982USD | — | — | — | — | — | — | — |
| Total Current Assets | 34,877,641USD | 9,267,128USD | 14,038,465USD | 13,621,698USD | 12,617,606USD | 14,892,668USD | 24,250,272USD | 35,899,189USD |
| Other Current Assets | 883,659USD | 920,038USD | 842,432USD | 1,067,409USD | 1,576,579USD | 987,495USD | 961,665USD | 1,635,818USD |
| Other Non Current Assets | 23,566USD | — | — | — | — | — | — | — |
| Total Liabilities | 6,767,253USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,237,711USD | 4,873,826USD | 4,749,737USD | 4,912,366USD | 5,866,661USD | 6,020,575USD | 9,387,757USD | 20,314,374USD |
| Total Stockholder Equity | 29,871,833USD | 4,717,110USD | 9,919,187USD | 9,379,329USD | 7,467,035USD | 8,253,389USD | 14,294,681USD | 15,164,940USD |
| Total Equity Including Noncontrolling Interest | 29,871,833USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,737,879USD | 1,822,853USD | 910,076USD | 976,112USD | 1,047,797USD | 1,119,742USD | 1,193,995USD | 1,364,297USD |
| Accounts Payable | 5,218,681USD | 4,724,826USD | 4,423,548USD | 4,014,682USD | 4,678,713USD | 3,874,429USD | 4,105,000USD | 8,304,311USD |
| Short Term Debt | 2,030USD | — | 100,189USD | 96,034USD | 92,022USD | 88,146USD | 84,417USD | 80,821USD |
| Common Stock | 83USD | 42USD | 42USD | 32USD | 18USD | 461USD | 461USD | 406USD |
| Retained Earnings | -281,718,099USD | -274,787,446USD | -269,133,500USD | -263,838,000USD | -259,394,000USD | -253,946,492USD | -247,342,463USD | -244,987,090USD |
| Total Liab | — | 6,402,651USD | 5,059,134USD | 5,248,261USD | 6,228,148USD | 7,788,801USD | 11,179,366USD | 22,128,326USD |
| Other Current Liab | — | 149,000USD | 226,000USD | 801,650USD | 1,095,926USD | 2,058,000USD | 5,198,340USD | 11,929,242USD |
| Capital Stock | — | 520,820USD | 520,820USD | 520,810USD | 520,796USD | 521,239USD | 521,239USD | 13,615,950USD |
| Cash | — | 8,347,090USD | 13,196,033USD | 12,554,289USD | 11,041,027USD | 13,905,173USD | 23,288,607USD | 34,263,371USD |
| Cash And Short Term Investments | — | 8,347,090USD | 13,196,033USD | 12,554,289USD | 11,041,027USD | 13,905,173USD | 23,288,607USD | 34,263,371USD |
| Net Debt | — | -6,818,265USD | -12,786,447USD | -12,122,360USD | -10,587,518USD | -13,430,824USD | -22,794,604USD | -33,750,621USD |
| Short Long Term Debt Total | — | 1,528,825USD | 409,586USD | 431,929USD | 453,509USD | 474,349USD | 494,003USD | 512,750USD |
| Property Plant Equipment Gross | — | 1,822,853USD | 2,095,671USD | 976,112USD | 1,047,797USD | 1,119,742USD | 2,217,874USD | 1,364,297USD |
| Common Stock Shares Outstanding | — | 4,240,129shares | 4,240,129shares | 3,162,040shares | 1,608,799shares | 1,535,995shares | 1,397,952shares | 1,311,197shares |
| Non Current Assets Total | — | 1,852,633USD | 939,855USD | 1,005,892USD | 1,077,577USD | 1,149,522USD | 1,223,775USD | 1,394,077USD |
| Non Current Liabilities Total | — | 1,528,824USD | 309,397USD | 335,895USD | 361,487USD | 1,768,226USD | 1,791,609USD | 1,813,952USD |
| Non Currrent Assets Other | — | 29,780USD | 29,779USD | 29,780USD | 29,780USD | 29,780USD | 29,780USD | 29,780USD |
| Net Working Capital | — | 4,393,302USD | 9,288,728USD | 8,709,332USD | 6,750,945USD | 8,872,093USD | 14,862,515USD | 15,584,815USD |
| Unclassified Non Current Liabilities | — | 1,528,824USD | — | — | — | 1,768,226USD | 1,791,609USD | 1,813,952USD |
| Unclassified Equity | — | 278,983,694USD | 278,531,825USD | 272,696,487USD | 266,340,221USD | 261,678,181USD | 261,115,444USD | 246,536,005USD |
| Other Assets | — | — | — | — | — | — | 121USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | -6,463,208USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | -331USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,978,321USD | 25,474,047USD | 12,075,580USD | 21,589,790USD | 37,201,809USD | 58,659,370USD | 12,250,811USD | 15,054,082USD |
| Other Current Assets | 842,432USD | 961,665USD | 888,225USD | 663,243USD | 867,485USD | 774,432USD | 770,951USD | 696,218USD |
| Total Liab | 5,059,134USD | 11,179,366USD | 25,852,525USD | 12,054,523USD | 4,156,655USD | 3,864,841USD | 3,191,402USD | 1,793,121USD |
| Total Stockholder Equity | 9,919,187USD | 14,294,681USD | -13,776,945USD | 9,535,267USD | 33,045,154USD | 54,794,529USD | 9,059,409USD | 13,260,961USD |
| Other Current Liab | 3,208,548USD | 5,198,340USD | 19,679,543USD | 8,892,695USD | 2,439,914USD | 2,014,000USD | 1,385,873USD | 76,090USD |
| Common Stock | 42USD | 461USD | 207USD | 94USD | 611USD | 454USD | 94USD | 47USD |
| Capital Stock | 520,820USD | 521,239USD | 6,059,862USD | 1,382,117USD | 1,382,634USD | 20,036,303USD | 1,148,298USD | 2,526,096USD |
| Retained Earnings | -269,133,500USD | -247,342,463USD | -202,761,017USD | -159,990,407USD | -150,897,789USD | -126,775,427USD | -111,681,255USD | -97,588,343USD |
| Cash | 13,196,033USD | 23,288,607USD | 9,564,988USD | 19,866,358USD | 35,703,975USD | 57,165,377USD | 10,614,722USD | 13,255,616USD |
| Cash And Short Term Investments | 13,196,033USD | 23,288,607USD | 9,564,988USD | 19,866,358USD | 35,703,975USD | 57,165,377USD | 10,614,722USD | 13,255,616USD |
| Total Current Assets | 14,038,465USD | 24,250,272USD | 10,453,213USD | 20,529,601USD | 36,571,460USD | 57,939,809USD | 11,385,673USD | 13,951,834USD |
| Total Current Liabilities | 4,749,737USD | 9,387,757USD | 25,358,522USD | 11,501,542USD | 3,990,363USD | 3,563,101USD | 2,769,758USD | 1,622,122USD |
| Net Debt | -12,786,447USD | -22,794,604USD | -9,012,006USD | -19,262,530USD | -35,402,234USD | -56,743,733USD | -10,087,193USD | -13,253,403USD |
| Short Term Debt | 100,189USD | 84,417USD | 58,979USD | 50,847USD | 135,449USD | 119,904USD | 105,885USD | 2,213USD |
| Short Long Term Debt Total | 409,586USD | 494,003USD | 552,982USD | 603,828USD | 301,741USD | 421,644USD | 527,529USD | 2,213USD |
| Accounts Payable | 1,441,000USD | 4,105,000USD | 5,620,000USD | 2,558,000USD | 1,415,000USD | 1,429,197USD | 1,278,000USD | 1,543,819USD |
| Property Plant Equipment Net | 910,076USD | 1,193,995USD | 1,592,587USD | 978,975USD | 549,135USD | 638,347USD | 783,924USD | 543,339USD |
| Property Plant Equipment Gross | 2,095,671USD | 2,217,874USD | 2,477,496USD | 978,975USD | 549,135USD | 355,982USD | 783,924USD | 543,339USD |
| Common Stock Shares Outstanding | 2,608,317shares | 1,238,125shares | 407,385shares | 235,188shares | 185,052shares | 66,042shares | 25,583shares | 9,873shares |
| Non Current Assets Total | 939,856USD | 1,223,775USD | 1,622,367USD | 1,060,189USD | 630,349USD | 719,561USD | 865,138USD | 1,102,248USD |
| Non Current Liabilities Total | 309,397USD | 1,791,609USD | 494,003USD | 552,981USD | 166,292USD | 301,740USD | 421,644USD | 171,000USD |
| Non Currrent Assets Other | 29,780USD | 29,780USD | 29,780USD | 81,214USD | 81,214USD | 81,214USD | 81,214USD | 558,909USD |
| Net Working Capital | 9,288,728USD | 14,862,515USD | -2,484,411USD | 15,000,311USD | 32,581,097USD | 54,376,708USD | 8,615,915USD | 12,329,712USD |
| Unclassified Equity | 278,531,825USD | 261,115,444USD | 184,306,026USD | 168,143,463USD | 182,559,698USD | 161,533,199USD | 119,901,677USD | 108,504,353USD |
| Unclassified Non Current Liabilities | — | 1,791,609USD | — | — | — | — | — | — |
| Accumulated Other Comprehensive Income | — | — | -1,382,023USD | — | — | 0USD | -309,405USD | -181,192USD |
| Other Assets | — | — | — | 81,214USD | 81,214USD | 363,579USD | 0USD | 0USD |
| Net Tangible Assets | — | — | — | 14,125,496USD | 31,663,131USD | 34,758,680USD | 7,911,205USD | 10,734,912USD |
| Current Deferred Revenue | — | — | — | — | 2,440,000USD | 2,014,000USD | 1,386,000USD | 965,090USD |
| Unclassified Current Liabilities | — | — | — | — | -2,440,000USD | -2,014,000USD | -1,386,000USD | — |
| Long Term Investments | — | — | — | — | — | 75,000USD | 75,000USD | 540,823USD |
| Non Current Liabilities Other | — | — | — | — | — | 301,740USD | 421,644USD | — |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 170,999USD |
| Other Liab | — | — | — | — | — | — | — | 170,999USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Short Term Investments | — | — | — | — | — | — | — | 55,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 880,175USD |
| Change To Liabilities | 795,133USD |
| Change In Working Capital | 1,083,224USD |
| Operating Cash Flow | -10,855,742USD |
| Capital Expenditures | -3,378USD |
| Investing Cash Flow | -3,378USD |
| Financing Cash Flow | 31,657,069USD |
| Change In Cash | 20,797,949USD |
| End Cash Flow | 33,993,982USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,653,946USD | -5,295,221USD | -4,443,877USD | -5,447,911USD | -6,604,029USD | -2,355,373USD | -14,664,718USD | -919,370USD |
| Depreciation | -110,018USD | 49,461USD | 52,277USD | 55,564USD | 56,295USD | 68,571USD | 68,571USD | 66,021USD |
| Stock Based Compensation | 451,869USD | 567,788USD | 567,788USD | 565,391USD | 562,737USD | 1,485,114USD | 1,534,053USD | 799,250USD |
| Other Non Cash Items | 371,623USD | 290,124USD | 292,920USD | -464,972USD | 340,000USD | -10,048,225USD | 1,671,579USD | 16,031USD |
| Change In Working Capital | 546,776USD | 611,500USD | -176,441USD | 176,402USD | -3,738,437USD | -63,565USD | 2,223,632USD | -1,647,498USD |
| Total Cash From Operating Activities | -4,845,565USD | -4,344,136USD | -4,275,121USD | -5,115,526USD | -9,383,434USD | -10,913,478USD | -9,166,883USD | -14,140,999USD |
| Capital Expenditures | -3,375USD | -5,884USD | -1USD | -61,286USD | 0USD | -61,286USD | -21,281USD | -21,276USD |
| Free Cash Flow | -4,848,940USD | -4,350,020USD | -4,275,120USD | -5,115,526USD | -9,383,434USD | -10,974,764USD | -9,166,883USD | -14,162,275USD |
| Total Cashflows From Investing Activities | -3,378USD | -5,880USD | — | 61,286USD | — | -61,286USD | -21,276USD | — |
| Change In Cash | -4,848,943USD | 641,744USD | 1,513,262USD | -2,864,146USD | -9,383,434USD | -10,974,764USD | 8,394,464USD | -14,162,274USD |
| Begin Period Cash Flow | 13,196,033USD | 12,554,289USD | 11,041,027USD | 13,905,173USD | 23,288,607USD | 34,263,371USD | 25,868,907USD | 40,031,181USD |
| End Period Cash Flow | 8,347,090USD | 13,196,033USD | 12,554,289USD | 11,041,027USD | 13,905,173USD | 23,288,607USD | 34,263,371USD | 25,868,907USD |
| Total Cash From Financing Activities | — | 4,991,760USD | 5,788,383USD | 2,251,380USD | 0USD | 0USD | 17,561,347USD | 1USD |
| Issuance Of Capital Stock | — | 0USD | — | — | — | 0USD | — | — |
| Unclassified Financing Cash Flow | — | 4,991,760USD | — | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | -61,286USD | 0USD | -21,276USD |
| Other Cashflows From Financing Activities | — | — | 5,788,383USD | 2,251,380USD | — | — | 17,561,347USD | — |
| Other Cashflows From Investing Activities | — | — | — | -61,286USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -12,455,433USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -21,791,037USD | -44,581,446USD | -42,770,610USD | -28,601,254USD | -24,122,362USD | -15,094,172USD | -14,092,912USD | -13,239,027USD |
| Depreciation | 213,597USD | 291,653USD | 192,375USD | 148,435USD | 149,915USD | 141,453USD | 132,798USD | 82,265USD |
| Stock Based Compensation | 2,263,704USD | 4,272,780USD | 2,410,288USD | 1,452,964USD | 1,124,190USD | 467,541USD | 866,791USD | 721,209USD |
| Other Non Cash Items | -677,505USD | -5,840,264USD | 4,315,165USD | 93,818USD | 80,658USD | -118,804USD | 13,562USD | 1,562,514USD |
| Change In Working Capital | -3,126,976USD | -1,725,724USD | 3,475,808USD | 1,683,736USD | 198,761USD | 671,239USD | 1,386,053USD | -569,053USD |
| Total Cash From Operating Activities | -23,118,217USD | -47,583,001USD | -32,376,974USD | -25,222,301USD | -22,568,838USD | -13,932,743USD | -11,693,708USD | -11,442,092USD |
| Capital Expenditures | -5,880USD | -104,199USD | -864,038USD | -225,971USD | -141,361USD | -62,353USD | -24,542USD | -384,993USD |
| Free Cash Flow | -23,124,100USD | -47,687,200USD | -33,241,012USD | -25,448,272USD | -22,710,199USD | -13,995,096USD | -11,718,250USD | -11,827,085USD |
| Total Cashflows From Investing Activities | -5,880USD | -104,195USD | -864,038USD | -225,971USD | -141,361USD | -62,353USD | -24,542USD | -329,993USD |
| Total Cash From Financing Activities | 13,031,523USD | 61,410,815USD | 22,939,642USD | 9,610,655USD | 1,248,797USD | 60,545,751USD | 9,022,356USD | 15,021,280USD |
| Issuance Of Capital Stock | 5,788,380USD | 0USD | 31,760,655USD | 9,610,655USD | 34,873USD | 59,719,256USD | 9,024,569USD | 15,025,078USD |
| Change In Cash | -10,092,574USD | 13,723,619USD | -10,301,370USD | -15,837,617USD | -21,461,402USD | 46,550,655USD | -2,695,894USD | 3,249,195USD |
| Begin Period Cash Flow | 23,288,607USD | 9,564,988USD | 19,866,358USD | 35,703,975USD | 57,165,377USD | 10,614,722USD | 13,310,616USD | 10,061,421USD |
| End Period Cash Flow | 13,196,033USD | 23,288,607USD | 9,564,988USD | 19,866,358USD | 35,703,975USD | 57,165,377USD | 10,614,722USD | 13,310,616USD |
| Other Cashflows From Financing Activities | 13,031,523USD | 61,410,815USD | 22,939,642USD | -9,610,655USD | 1,213,924USD | 642,495USD | 9,022USD | 5,948,539USD |
| Unclassified Financing Cash Flow | -5,788,380USD | — | -31,760,655USD | 9,610,655USD | — | 59,076,761USD | — | 3,126,476USD |
| Investments | — | -104,195USD | -715,138USD | -225,971USD | -141,361USD | -62,353USD | -24,542USD | -329,993USD |
| Change To Liabilities | — | — | — | 1,623,529USD | 411,717USD | 780,604USD | 1,120,054USD | -258,794USD |
| Net Borrowings | — | — | — | — | 0USD | 184,000USD | -2,213USD | -3,036USD |
| Sale Purchase Of Stock | — | — | — | — | — | 642,495USD | 9,024,569USD | 8,191,096USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 46,550,655USD | -2,695,894USD | 3,249,195USD |
| Dividends Paid | — | — | — | — | — | — | — | -2,241,795USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 55,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.